Global impact of monoclonal antibodies (mAbs) in children: A focus on anti-GD2
Simple Summary Despite being in use for almost 50 years, monoclonal antibodies face
limitations in their implementation in clinical practice, particularly in pediatrics and pediatric …
limitations in their implementation in clinical practice, particularly in pediatrics and pediatric …
GD2-targeting therapy: a comparative analysis of approaches and promising directions
J Philippova, J Shevchenko, S Sennikov - Frontiers in Immunology, 2024 - frontiersin.org
Disialoganglioside GD2 is a promising target for immunotherapy with expression primarily
restricted to neuroectodermal and epithelial tumor cells. Although its role in the maintenance …
restricted to neuroectodermal and epithelial tumor cells. Although its role in the maintenance …
B3GALT4 remodels the tumor microenvironment through GD2-mediated lipid raft formation and the c-met/AKT/mTOR/IRF-1 axis in neuroblastoma
YL Sha, Y Liu, JX Yang, YY Wang, BC Gong… - Journal of Experimental …, 2022 - Springer
Abstract Background Beta-1, 3-galactosyltransferase-4 (B3GALT4) plays a critical regulatory
role in tumor biology. However, the role of B3GALT4 in modulating the tumor …
role in tumor biology. However, the role of B3GALT4 in modulating the tumor …
Gd2 expression in Medulloblastoma and neuroblastoma for personalized Immunotherapy: A matter of subtype
C Paret, A Ustjanzew, S Ersali, L Seidmann… - Cancers, 2022 - mdpi.com
Simple Summary Molecular analyses discussed in Molecular Tumor Boards are expected to
improve cancer treatment by identifying tumor-specific alterations. Here, we quantified the …
improve cancer treatment by identifying tumor-specific alterations. Here, we quantified the …
A novel cuproptosis-related subtypes and gene signature associates with immunophenotype and predicts prognosis accurately in neuroblastoma
XM Tian, B Xiang, YH Yu, Q Li, ZX Zhang… - Frontiers in …, 2022 - frontiersin.org
Background Neuroblastoma (NB) is the most frequent solid tumor in pediatrics, which
accounts for roughly 15% of cancer-related mortality in children. NB exhibited genetic …
accounts for roughly 15% of cancer-related mortality in children. NB exhibited genetic …
[HTML][HTML] A novel ganglioside-related risk signature can reveal the distinct immune landscape of neuroblastoma and predict the immunotherapeutic response
J Yang, L Han, Y Sha, Y Jin, Z Li, B Gong, J Li… - Frontiers in …, 2022 - frontiersin.org
Introduction Gangliosides play an essential role in cancer development and progression.
However, the involvement of gangliosides in the prognosis and tumor microenvironment …
However, the involvement of gangliosides in the prognosis and tumor microenvironment …
GDPD5 related to lipid metabolism is a potential prognostic biomarker in neuroblastoma
T Luo, J Peng, Q Li, Y Zhang, Y Huang, L Xu… - International Journal of …, 2022 - mdpi.com
Neuroblastoma (NB) is an extracranial solid tumor in children with poor prognosis in high-
risk patients and its pathogenesis and prognostic markers urgently need to be explored. This …
risk patients and its pathogenesis and prognostic markers urgently need to be explored. This …
[HTML][HTML] Integrating TCGA and Single-Cell Sequencing Data for Hepatocellular Carcinoma: A Novel Glycosylation (GLY)/Tumor Microenvironment (TME) Classifier to …
Y Wu, J Chen, R Zhu, G Huang, J Zeng, H Yu, Z He… - Metabolites, 2024 - mdpi.com
The major liver cancer subtype is hepatocellular carcinoma (HCC). Studies have indicated
that a better prognosis is related to the presence of tumor-infiltrating lymphocytes (TILs) in …
that a better prognosis is related to the presence of tumor-infiltrating lymphocytes (TILs) in …
Immunotherapy Options for Neuroblastoma: What is on the Horizon?
A Karakus, B Berberogullari - Current Molecular Biology Reports, 2024 - Springer
Abstract Purpose of Review Neuroblastoma is the most commonly seen extracranial tumor
in children originating from the sympathetic nervous system. It is responsible for …
in children originating from the sympathetic nervous system. It is responsible for …
[PDF][PDF] GD2 Expression in Medulloblastoma and Neuroblastoma for Personalized Immunotherapy: A Matter of Subtype. Cancers 2022, 14, 6051
C Paret, A Ustjanzew, S Ersali, L Seidmann… - 2022 - researchgate.net
Neuroblastoma (NBL) and medulloblastoma (MB) are aggressive pediatric cancers which
can benefit from therapies targeting gangliosides. Therefore, we compared the ganglioside …
can benefit from therapies targeting gangliosides. Therefore, we compared the ganglioside …